Opendata, web and dolomites


An affordable Multi-analyte Point-of-Care system for Chronic Disease Self-Control and Management

Total Cost €


EC-Contrib. €






 PoCMICRUX project word cloud

Explore the words cloud of the PoCMICRUX project. It provides you a very rough idea of what is the project "PoCMICRUX" about.

micrux    electrochemical    microfluidic    overcome    diseases    150    action    expenditure    technologies    miniaturized    poc    cumulative    700    poct    glucose    57    acid    foresee    billion    first    min    budget    chip    launching    electronical    2008    monitoring    self    totally    simply    fluid    too    barrier    patients    tools    expensive    sensor    70    analyte    remarkable    succeeded    diabetes    spanish    cholesterol    life    handled    countries    company    create    jobs    expectancies    2023    kidney    pocmicrux    creatinine    million    models    intend    handheld    simultaneously    afforded    forefront    people    home    point    profitability    components    accumulated    biomarkers    combination    foundation    dramatically    cardiovascular    marketed    device    health    training    made    lifestyle    prevalence    unhealthy    26    fast    chronic    ratio    multiple    commercialization    lt    market    uric    longer    lab    calibration    care    total    innovative    diagnostic    profit    clinical    capillary    instrumentation    disease    accurately    turnover    validated    blood    drop    prevention    healthcare   

Project "PoCMICRUX" data sheet

The following table provides information about the project.


Organization address
city: OVIEDO
postcode: 33006

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MICRUX FLUIDIC SL ES (OVIEDO) coordinator 50˙000.00


 Project objective

Longer life expectancies and unhealthy lifestyle has dramatically increase the prevalence multiple chronic conditions. There are over 50 million of people with such cumulative chronic conditions in Europe and, together, they total more than €700 billion healthcare expenditure which account for over 70% of the EU health budget. Recent Point-of-Care Testing (PoCT) technologies provide remarkable tools for home self-testing and management but the currently PoC on the market are still so complex and too expensive to be afforded by average patients. With PoCMicruX we intend to overcome this barrier and finally provide patients the first low-cost multi-analyte handheld Point-of-Care device for multiple chronic disease self-testing and management. PoCMicruX is a combination of microfluidic and electrochemical sensor technologies. Based on an innovative design totally made of electronical components and where fluid can simply be handled by capillary action, we will offer the only cost-effective (€150), simple (one drop of blood, no training or calibration required), fast (<2 min), and handheld PoC device allowing patients to accurately self-test simultaneously four clinical validated biomarkers (glucose, cholesterol, creatinine and uric acid) for the clinical diagnostic (monitoring and prevention) of high prevalence diseases such as diabetes, cholesterol, cardiovascular and kidney diseases. MicruX Technologies is a highly innovative Spanish company that, from its foundation in 2008, has been at the forefront of developing miniaturized lab-on-chip technology and miniaturized monitoring instrumentation, being already involved in several EU projects. We have already succeeded in launching more than 30 models of products currently marketed in 40 countries. We expect from PoCMicruX commercialization to provide an accumulated turnover of €26.7 million by 2023, with 8.5 million profit (profitability ratio of 57%). We foresee to create 50 new jobs by 2023.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "POCMICRUX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "POCMICRUX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More  

GREEN WHS (2019)


Read More